Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange Detected- The page now shows a new Revision: v3.5.4, replacing the prior v3.5.3, indicating a software version bump. This change reflects an internal update to the site rather than a modification to study information.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows Revision: v3.5.3 instead of Revision: v3.5.2. This reflects a minor update to the page's content or presentation.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe site version was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Revision: v3.5.0. Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated to v3.4.3 (from v3.4.2).SummaryDifference0.0%

- Check94 days agoChange DetectedThe page adds a reference to Primary peritoneal carcinoma and a Genetic and Rare Diseases Information Center resource, and removes the government funding notice. A revision note (v3.4.2) is also shown.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.